| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CNS Pharmaceuticals Inc (NASDAQ: CNSP)
CNSP Technical Analysis
4
| As on 21st Feb 2025 CNSP SHARE Price closed @ 3.23 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.08 & Strong Buy for SHORT-TERM with Stoploss of 1.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CNSPSHARE Price
| Open | 3.30 | Change | Price | % |
| High | 3.70 | 1 Day | 3.15 | 3937.50 |
| Low | 2.81 | 1 Week | 3.12 | 2836.36 |
| Close | 3.23 | 1 Month | 3.12 | 2836.36 |
| Volume | 664647 | 1 Year | 1.67 | 107.05 |
| 52 Week High 5.39 | 52 Week Low 0.08 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| UPC | 0.20 | 42.86% |
| ADTX | 0.09 | -25.00% |
| NVDA | 134.43 | -4.05% |
| LMDX | 0.02 | 0.00% |
| INTC | 24.87 | -4.68% |
| SMCI | 56.07 | -5.40% |
| AKTS | 0.04 | 0.00% |
| LCID | 3.06 | -7.55% |
| BHAT | 0.05 | -16.67% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CNSP Daily Charts |
CNSP Intraday Charts |
Whats New @ Bazaartrend |
CNSP Free Analysis |
|
|
CNSP Important Levels Intraday
| RESISTANCE | 4.95 |
| RESISTANCE | 4.40 |
| RESISTANCE | 4.06 |
| RESISTANCE | 3.72 |
| SUPPORT | 2.74 |
| SUPPORT | 2.40 |
| SUPPORT | 2.06 |
| SUPPORT | 1.51 |
CNSP Forecast February 2025
| 4th UP Forecast | 6.53 |
| 3rd UP Forecast | 5.47 |
| 2nd UP Forecast | 4.82 |
| 1st UP Forecast | 4.16 |
| 1st DOWN Forecast | 2.3 |
| 2nd DOWN Forecast | 1.64 |
| 3rd DOWN Forecast | 0.99 |
| 4th DOWN Forecast | -0.07 |
CNSP Weekly Forecast
| 4th UP Forecast | 3.89 |
| 3rd UP Forecast | 3.68 |
| 2nd UP Forecast | 3.55 |
| 1st UP Forecast | 3.42 |
| 1st DOWN Forecast | 3.04 |
| 2nd DOWN Forecast | 2.91 |
| 3rd DOWN Forecast | 2.78 |
| 4th DOWN Forecast | 2.57 |
CNSP Forecast2025
| 4th UP Forecast | 19.05 |
| 3rd UP Forecast | 13.98 |
| 2nd UP Forecast | 10.84 |
| 1st UP Forecast | 7.7 |
| 1st DOWN Forecast | -1.24 |
| 2nd DOWN Forecast | -4.38 |
| 3rd DOWN Forecast | -7.52 |
| 4th DOWN Forecast | -12.59 |
CNS Pharmaceuticals Inc ( NASDAQ USA Symbol : CNSP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CNSP Business Profile
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was founded in 2017 and is based in Houston, Texas. Address: 2100 West Loop South, Houston, TX, United States, 77027
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service